Yousra M. El‐Far

Nanoformulated Natural Therapeutics for Management of streptozotocin-induced Diabetes: Potential Use of Curcumin Nanoformulation

Yousra M. El‐Far, Mahmoud M. Zakaria, Amal M. El Gayar et al. · Nanomedicine · 2017 · 54 citations

Life Sciences, Biochemistry, Pharmacology +17

A Newly Developed Silymarin Nanoformulation As a Potential Antidiabetic Agent in Experimental Diabetes

Yousra M. El‐Far, Mahmoud M. Zakaria, Amal M. El Gayar et al. · Nanomedicine · 2016 · 49 citations

Medicine, Biotechnology, Pharmacology +17

Novel doxorubicin / folate-targeted trans-ferulic acid-loaded PLGA nanoparticles combination: In-vivo superiority over standard chemotherapeutic regimen for breast cancer treatment

Sahar A Helmy, Saif El-Mofty, Amal M. El Gayar et al. · Biomedicine & Pharmacotherapy · 2021 · 42 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Chemopreventive and hepatoprotective effects of genistein via inhibition of oxidative stress and the versican/PDGF/PKC signaling pathway in experimentally induced hepatocellular carcinoma in rats by thioacetamide

Yousra M. El‐Far, Ahmed E. Khodir, Ziad Emarah et al. · Redox Report · 2022 · 36 citations · Full text

Medicine, Oncology, Pharmacology +17

Effect of zinc oxide nanoparticles and ferulic acid on renal ischemia/reperfusion injury: possible underlying mechanisms

Amira Awadalla, Abdelaziz M. Hussein, Yousra M. El‐Far et al. · Biomedicine & Pharmacotherapy · 2021 · 35 citations · Full text

Medicine, Nephrology, Pharmacology +17